Combination drug therapy for Alzheimer's disease: What is evidence-based, and what is not?

Geriatrics

Volumn 60, Issue 6, 2005, Pages 22-26

  Xiong, Glen ^a   Doraiswamy, P Murali ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Cholinesterase inhibitor; Memantine combination drug therapy; Polypharmacy

Indexed keywords

ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; ESTROGEN; GALANTAMINE; GINKGO BILOBA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMANTINE; MOOD STABILIZER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RIVASTIGMINE; SELEGILINE; TACRINE; VITAMIN;

ALZHEIMER DISEASE; BEHAVIOR; CLINICAL TRIAL; COGNITION; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HORMONE SUBSTITUTION; HUMAN; MONOTHERAPY; NEUROPSYCHOLOGICAL TEST; PATIENT CARE; POLYPHARMACY; REVIEW; STANDARD; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CHOLINESTERASE INHIBITORS; DRUG THERAPY, COMBINATION; ESTROGENS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEMANTINE; POLYPHARMACY;

EID: 20544449738     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Doraiswamy PM, Steffens, DC. Combination therapy for early Alzheimer's disease: What are we waiting for? J Am Geriatr Soc 1998; 46(10):1322-4.
2. Doraiswamy PM. Interventions for mild cognitive impairment and Alzheimer disease: New strategies, new hope. Am J Geriatr Psychiatry 2003; 11(2):120-2.
3. Cummings JL. Alzheimer's disease. N Engl J Med 2004; 351(1):56-67.
4. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomized trials. BMJ 2003; 326(7404):1427.
5. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289(19):2560-72.
6. Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to several Alzheimer disease already receiving donepezil: A randomized controlled trial. JAMA 2004; 291(3):317-24.
7. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997; 336(17):1216-22.
8. Schneider LS, Farlow M. Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease. Ann N Y Acad Sci 1997; 826:317-22.
9. Rigaud AS, Andre G, Vellas B, Touchon J, Pere JJ; French Study Group. No additional benefit of HRT on response to rivastigmine in menopausal women with AD. Neurology 2003; 60(1):148-9.
10. Klatte ET, Scharre DW, Nagaraja HN, Davis RA, Beversdorf DQ. Combination therapy of donepezil and vitamin E in Alzheimer disease. Alzheimer Dis Assoc Disord 2003; 17(2):113-6.
11. Gutterman EM, Markowitz JS, Joan Amatniek J, et al. Effects of statins on cognitive maintenance of patients with Alzheimer disease in pooled, randomized, placebo-controlled clinical trials of galantamine. Poster presented at 7th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy. April 3-6, 2002. Geneva, Switzerland.
12. Reisberg B, Doody R, Stoffler A, et al. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003; 348(14):1333-41.
13. Feldman H, Gauthier S, Hecker J, et al. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geratr Soc 2003; 51(6):737-44.
14. Drachman DA, Leber P. Treatment of Alzheimer's Disease-searching for a breakthrough, settling for less. N Engl J Med 1997; 336(17):1245-7.
15. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291(24):2959-68.
16. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Do nonsteroidal anti-inflammtory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995; 45(8):1441-5.
17. Sparks DL, Sabbagh M, Connor DJ, et al. Benefits of atorvastatin in subjects with Alzheimer's disease: Abstract. Circ, In press.
18. Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 2004; 19(1):9-18.